ANO1 and neoplasm: Based on the twelve factors (including age, sex, tumor location, tumor diameter, recurrence risk, CD117, DOG-1, CD34, ulcer, mitotic count, bleeding, and necrosis), the differences in distribution among the mutations by merging the five mutation types into three groups (point mutations, deletion/compound mutations and insertion/tandem duplication mutations) were compared subsequently.